Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05005949 · ClinicalTrials.gov registry record

STOP Persistent AF PAS

A clinical trial of Persistent Atrial Fibrillation, sponsored by Medtronic Cardiac Ablation Solutions.

Active
Registry status
400
Enrollment target
17
Study locations

NCT05005949 is a study of Persistent Atrial Fibrillation that is active but no longer recruiting, run by Medtronic Cardiac Ablation Solutions. The registered enrollment target is 400 participants, below the 1,234-participant average among 15 other Persistent Atrial Fibrillation trials with a reported enrollment target (68% lower). The trial reports 17 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05005949, a study of Persistent Atrial Fibrillation, is active but no longer recruiting, sponsored by Medtronic Cardiac Ablation Solutions.

ACTIVE NOT RECRUITING
Registry status
400 participants
Enrollment target
17
Study locations

Study Summary

The STOP Persistent AF Post Approval Study (PAS) is a prospective, global, multicenter, observational trial.

Conditions Studied

Persistent Atrial Fibrillation

Interventions

  • DEVICE Arctic Front™ Cardiac Cryoablation Catheter System

Study Locations (17)

Other

  • Kepler Universitätsklinikum Med Campus III. - Linz
  • St. Vinzenz-Hospital Köln - Cologne
  • MVZ CCB Frankfurt und Main Taunus - Frankfurt am Main
  • Städtische Kliniken München GmbH - Klinikum Bogenhausen - München
  • Universitaria Pisana - Stabilimento di Cisanello - Pisa
  • Centralny Szpital Kliniczny Uniwersytetu Medycznego w Łodz - Lodz
  • Liverpool Heart and Chest Hospital NHS Foundation Trust - Liverpool

Connecticut

  • Hartford Hospital - Hartford
  • Cardiology Associates of Fairfield County - Stamford

Florida

  • BayCare Medical Group Cardiology - Clearwater
  • Heart Rhythms Solutions - Davie

Michigan

  • Henry Ford Heart & Vascular - Detroit
  • Spectrum Health Hospitals - Grand Rapids

Texas

  • Texas Cardiac Arrhythmia Research Foundation - Austin
  • Texas Health Research & Education Institute - Dallas

Illinois

  • Carle Foundation Hospital - Urbana

Ohio

  • The Lindner Research Center - Cincinnati

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2021-08-19
Est. Completion 2028-07

Sponsor

Medtronic Cardiac Ablation Solutions

20 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05005949

The ClinicalTrials.gov registry entry for NCT05005949 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,234-participant average among 15 other Persistent Atrial Fibrillation trials with a reported enrollment target (68% lower). The listed sponsor is Medtronic Cardiac Ablation Solutions, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Persistent Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Arctic Front™ Cardiac Cryoablation Catheter System is the first listed.

NCT05005949 reports 17 study locations spanning 7 distinct geographic areas - top geographies include Other, Connecticut, Florida.

Frequently Asked Questions

What is clinical trial NCT05005949 about?

NCT05005949 is a clinical study titled "STOP Persistent AF PAS". The STOP Persistent AF Post Approval Study (PAS) is a prospective, global, multicenter, observational trial.

What is the current status of trial NCT05005949?

This trial is currently active not recruiting. The enrollment target is 400 participants. The study started on 2021-08-19. Estimated completion is 2028-07.

What conditions does trial NCT05005949 study?

This clinical trial studies the following conditions: Persistent Atrial Fibrillation.

What interventions are being tested in trial NCT05005949?

The interventions under investigation include: Arctic Front™ Cardiac Cryoablation Catheter System (DEVICE).

Who is sponsoring clinical trial NCT05005949?

This trial is sponsored by Medtronic Cardiac Ablation Solutions, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05005949 being conducted?

This trial has 17 study locations across Connecticut, Florida, Illinois, Michigan, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Persistent Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Persistent Atrial Fibrillation

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.